Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40015443

Informations générales

Localisation

China

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

20/11/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2034

Statut

Targets set

Classification

1.5°C

Année cible

2034

Progression vers l'objectif58%
2015 (année de référence)2034
Description complète des objectifs

Near-Term Targets: Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd commits to reduce absolute scope 1 and 2 GHG emissions 58.8% by 2034 from a 2024 base year. Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel- and energy-related activities, upstream transportation and distribution, processing of sold products and investments 35.0% within the same timeframe.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques